“…Furthermore, TDP-43 forms liquid-liquid phase separated droplet-like structures in the nucleus (Murray et al, 2017;Guo et al, 2018;Maharana et al, 2018;Gasset-Rosa et al, 2019;Mann et al, 2019;Bhopatkar et al, 2020), as well as physiological oligomers through interaction of its N-terminal domains, which regulate RNA splicing (Afroz et al, 2017;Wang et al, 2018). In disease, TDP-43 forms amyloid fibrils via association of its low complexity domains at the C-terminal site (Babinchak et al, 2019;Cao et al, 2019;Shenoy et al, 2020;Li et al, 2021). Upon oxidative stress or destabilization of physiological oligomerization, nuclear droplets unmix and TDP-43 translocates to the cytoplasm where it incorporates into cytoplasmic droplets leading to cellular toxicity (Afroz et al, 2017;Gasset-Rosa et al, 2019).…”